Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
Conditions:  Type 1 Diabetes;  Diabetic Kidney Disease;  Diabetes Complications;  Diabetic Nephropathies;  Autoimmune Diabetes Interventions:  Drug: Aminohippurate Sodium Inj 20% Diagnostic aid/agent used to measure effective renal plasma flow (ERPF);  Drug: Iohexol Inj 300 MG/ML Diagnostic aid/agent used to measure glomerular filtration rate (GFR) Sponsors:  University of Colorado, Denver;  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 1 | Endocrinology | Iohexol | Omnipaque | Research | Sodium | Study | Urology & Nephrology